2027 Medicare Advantage Final Rule, Rate Released
CMS finalized the 2027 Medicare Advantage and Part D rule, updating benefits, cost sharing, Star Ratings policies, and payment rates for plans.
Read moreACR emphasized the importance of bringing cancer screening directly to the communities that need it most to ensure early detection and intervention.
ACR® joined multiple medical organizations in expressing support for the Mobile Cancer Screening Act (H.R. 4417). The bipartisan bill, introduced in July by cosponsors U.S. Reps. Raul Ruiz, MD (D-CA), Gabe Evans (R-CO) and Debbie Wasserman Schultz (D-FL), would significantly enhance access to cancer screening services for underserved and rural communities across the United States.
The organizations emphasized to cosponsors the importance of bringing cancer screening directly to the communities that need it most to ensure early detection and intervention, regardless of geographic location or socioeconomic status. They told lawmakers they will work them to advance the bill through Congress.
ACR and the medical community look forward to working with Congress to advance this legislation. For more information or if you have questions, contact Ashley Walton, ACR Government Affairs Director.
2027 Medicare Advantage Final Rule, Rate Released
CMS finalized the 2027 Medicare Advantage and Part D rule, updating benefits, cost sharing, Star Ratings policies, and payment rates for plans.
Read morePhysician Groups Warn Visa Delays Could Impact Patient Care
More than 30 medical organizations, including the ACR®️, urged federal officials to address immigration barriers preventing international medical graduates (IMGs) from lawfully entering or remaining in the U.S.
Read moreACR Submits Testimony to Congress
ACR®️ submitted testimony to the U.S. House Committee on Appropriations Labor urging strong federal funding for medical research in federal fiscal year 2027.
Read more